Pharmaceuticals News

Subscribe to pharmaceutical news about research, development, manufacturing and marketing of prescription and over the counter drugs. Find the latest on FDA approvals, compliance, competition, management and distribution of pharmaceutical products as well as pharmaceutical business intelligence.

NuvOx Newly Issued US Patent

NuvOx Pharma (NuvOx), a clinical stage biotechnology company developing a first-in-class therapeutic to treat life-threatening diseases where hypoxia plays a role, announced that it has been issued US Patent No. 11,571,467, “Dodecafluoropentane emulsion (DDFPe) as a stroke and ischemia... - March 02, 2023 - NuvOx Therapeutics

North Texas Plastic Surgery to Offer Semaglutide Weight Loss Treatment

North Texas Plastic Surgery to Offer Semaglutide Weight Loss Treatment

The biggest advancement in weight loss treatment is now being offered at North Texas Plastic Surgery in Dallas. - February 17, 2023 - North Texas Plastic Surgery

Author Amanda Mullins’s New Book, "Pharmacology for Babies," Lays the Groundwork for Introducing the Basic Concepts of Pharmacology at a Young Age

Author Amanda Mullins’s New Book, "Pharmacology for Babies," Lays the Groundwork for Introducing the Basic Concepts of Pharmacology at a Young Age

Recent release “Pharmacology for Babies,” from Page Publishing author Amanda Mullins, is a unique children’s book that breaks down basic concepts of pharmacology for young readers and listeners. - February 17, 2023 - Page Publishing

Creative Biolabs Updated Solutions to Support the Intensive Research on Exosomes

A recent market report reveals the huge potential of exosome research, which is gaining mounting research fever across the industry. - February 11, 2023 - Creative Biolabs

Former FDA Investigator Launches cGMP Quality Systems Certification

Former FDA Investigator Launches cGMP Quality Systems Certification

With increased actions against pharmaceutical companies, a former FDA Investigator has launched an auditing service to certify any or all of the Quality systems reviewed during FDA inspections. The audits must be on-site and conclude without any Major or Critical observations in order to receive a certificate for the system(s) observed. - February 09, 2023 - FD-AID, LLC

BDA Partners Advises Synokem Pharma on Strategic Growth Investment from TA Associates

BDA Partners is pleased to announce that its client, Synokem Pharmaceuticals Ltd, has received a strategic growth investment from TA Associates. Synokem is a fast-growing, India-based CDMO (contract development and manufacturing organization) with R&D capabilities, manufacturing finished... - January 19, 2023 - BDA Partners Ltd

Zifo R&D Solutions Announces Acquisition of beyontics GmbH

Zifo, a leading global specialist scientific informatics services provider, announces the acquisition of beyontics™. A scientific service provider, beyontics has extensive experience in selecting, configuring, optimizing, and supporting Chromatography Data Systems (CDS), particularly the... - January 19, 2023 - Zifo

Genesis AEC Celebrates 25th Anniversary

Leading AEC firm’s milestone includes 8,300+ projects for 600+ life sciences leaders nationwide. - January 18, 2023 - Genesis AEC

First Overseas Shipment of CanSinoBIO’s Convidecia Air™ Delivered to Morocco

CanSino Biologics Inc. (“CanSinoBIO” or “the Company”) (SSE: 688185, HKEX: 06185) today announced that the first batch of its Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) for Inhalation (trade name: Convidecia Air™) has arrived in Morocco, providing... - December 30, 2022 - CanSinoBIO

Paras Biopharmaceuticals Creates Excellence with “Continuous Biomanufacturing”: Achieves Objectives of “High Productivity & Biomanufacturing Innovation”

Paras Biopharmaceuticals Creates Excellence with “Continuous Biomanufacturing”: Achieves Objectives of “High Productivity & Biomanufacturing Innovation”

With 6 years of dedicated work at Paras Biopharmaceuticals and the use of Paras Biopharmaceuticals’ unique technology platform (which comprises of Bioproduction technologies for economical production of biologics), the company is pleased to announce that an excellent scale-up production process is achieved with “Continuous Biomanufacturing.” - December 19, 2022 - Paras Biopharmaceuticals Finland Oy

Conference Co-Chairs from Merck & AstraZeneca Invitation to Join 3D Cell Culture

SAE Media Group reports: Conference co-chairs invite delegates to join the anticipated 6th Annual 3D Cell Culture Conference. - December 16, 2022 - SAE Media Group

Paras Biopharma Streamlines Offerings as “Biologics CDMO” and Biosimilar Co-Development as “Paras Biologics”

Paras Biopharma Streamlines Offerings as “Biologics CDMO” and Biosimilar Co-Development as “Paras Biologics”

Paras Biopharmaceuticals Finland Oy today revealed that the company has streamlined and enhanced its business activities with the establishment of a division called, Paras Biologics. In addition to its existing biologics CDMO activities and capabilities (this division is now referred to as Paras Biopharma), the creation of Paras Biologics enhances the company’s biologics and biosimilar pipeline for co-development and licensing opportunities. - December 11, 2022 - Paras Biopharmaceuticals Finland Oy

PharmStars Announces Fall 2022 Accelerator Graduates: 11 Digital Health Startups Complete PharmStars’ Pharma-Focused Accelerator Program

PharmStars Announces Fall 2022 Accelerator Graduates: 11 Digital Health Startups Complete PharmStars’ Pharma-Focused Accelerator Program

PharmStars, the pharma-focused accelerator for digital health startups, announces the graduation of 11 startups from its Fall 2022 program focused on “Innovations in Real-World Evidence.” The graduating startups successfully completed PharmaU, PharmStars’ 10-week education, and mentoring program. PharmaU culminated with a Showcase Event--held in Boston in early November--that brought together the participating startups and PharmStars’ seven innovation-minded pharma members. - December 08, 2022 - PharmStars

PharmStars Announces “Innovations in Women’s Health and Health Equity” Theme for Spring 2023 Accelerator

PharmStars Announces “Innovations in Women’s Health and Health Equity” Theme for Spring 2023 Accelerator

PharmStars, the pharma-focused accelerator for digital health startups, is now accepting applications for its Spring 2023 cohort with the theme “Digital Innovations in Women’s Health and Health Equity.” Startups with digital innovations that promote more equitable, inclusive healthcare for underserved population or focused on women’s health (e.g., breast, ovarian, and cervical cancer; gynecological conditions; osteoporosis; menopausal, hormonal, and reproductive conditions) are welcome to apply. - December 05, 2022 - PharmStars

Ramsey Asmar, MD Joins New York Cancer & Blood Specialists

Ramsey Asmar, MD Joins New York Cancer & Blood Specialists

New York Cancer & Blood Specialists (NYCBS), one of the nation’s leading oncology practices, is proud to announce the addition of board-certified hematologist-oncologist Ramsey Asmar, MD. He will practice at 2236 Nostrand Avenue, Brooklyn, NY 11205. “We are very excited to welcome... - December 01, 2022 - New York Cancer & Blood Specialists

Paras Biopharmaceuticals Finland Oy is Highly Recommended for Biologics CDMO – Development / Scale-up & Production of Biologics by Innovative USA Biopharma Company

Paras Biopharmaceuticals is pleased to announce that the company has been highly recommended for its Biologics CDMO – development / scale-up and production capabilities. The Paras Biopharmaceuticals Team has successfully completed multiple biologics projects in 2022. - November 29, 2022 - Paras Biopharmaceuticals Finland Oy

Exploring the Implementation of Complex In-Vitro Models for Drug Development

SAE Media Group reports: Agenda and speaker overview released for the 6th Annual 3D Cell Culture Conference, London, UK. - November 28, 2022 - SAE Media Group

Novugen Pharma Became the First Pharmaceutical Company in Malaysia to Receive USFDA Approval for Its Manufacturing Facility

Novugen Pharma Became the First Pharmaceutical Company in Malaysia to Receive USFDA Approval for Its Manufacturing Facility

The Company was audited in September 2022 and USFDA issued an Establishment Inspection Report (EIR) in November 2022. Novugen Pharma is the first USFDA approved pharmaceutical manufacturing in Malaysia and the only in Southeast Asia. - November 22, 2022 - Novugen

Biomed Industries, Inc. Comments on Roche’s Alzheimer’s Phase III Trial

In a news release dated November 14, 2022, Roche announced that their Alzheimer’s drug candidate, gantenerumab, did not perform meaningfully better than a placebo. About 25% of all patients who received gantenerumab were also associated with higher rates of an imaging abnormality that can... - November 19, 2022 - Biomed Industries Inc.

Virb Lands Contract with $10B Life Sciences Company

Virb Lands Contract with $10B Life Sciences Company

Begins Series A Financing to Accelerate Growth in the Clinical Research Industry. - November 16, 2022 - Virb

Nuvem, a Leading Pharmacy Technology & Services Company, Appoints New CEO

Nuvem (or the “Company”), a high-growth, healthcare technology company offering an integrated suite of pharmacy claims administration technology, related analytics and onsite pharmacy management services to safety net healthcare providers, announced that Matthew Umscheid has joined the... - November 10, 2022 - Nuvem

PharmStars Announces Fall 2022 Startup Showcase Event

PharmStars Announces Fall 2022 Startup Showcase Event

PharmStars, the pharma-focused accelerator for digital health startups, announces that its Fall 2022 Showcase Event will begin on November 8, 2022. The Showcase is the culmination of a 10-week startup accelerator program. At the Showcase Event, startups will make formal presentations to and meet... - November 08, 2022 - PharmStars

Biomed Industries, Inc. (“Biomed”) Today Announced the Closing of Its Merger with MedAware Systems, Inc., (“MedAware”)

Biomed Industries, Inc. (“Biomed”) today announced the closing of its merger with MedAware Systems, Inc., (“MedAware”), in which all issued and outstanding common shares of capital stock of MedAware will be exchanged for common stock of Biomed at a ratio of 5.33 shares of MedAware for 1 new common share of Biomed. The transaction valued at an aggregate of $20 million, to be paid by 2,259,170 common shares of Biomed. At present, Biomed has approximately 76,354,075 common shares issued. - November 07, 2022 - Biomed Industries, Inc.

Thaddeus Medical Customizable Cold-Chain iQ-Ler Now Available for Pre-Order

Thaddeus Medical Customizable Cold-Chain iQ-Ler Now Available for Pre-Order

Cold Chain system is designed for storage, transportation and dispensary of temperature-sensitive medical therapeutics to eliminate all spoilage in cold-chain logistics and improve patient outcomes - November 03, 2022 - Thaddeus Medical

Pharma/Vaccine Exec Brad Thompson Joins Fuld & Company as Advisory Board Member

Pharma/Vaccine Exec Brad Thompson Joins Fuld & Company as Advisory Board Member

Fuld & Company welcomes Pharma/Vaccine Exec Brad Thompson as an Advisory Board Member. Brad brings over twenty years of experience building franchise and brand strategies in the vaccine and pharmaceutical space. He will be an instrumental member of Fuld's HLS team to help propel the success of the company's pharma and biotech clients. - November 03, 2022 - Fuld & Company

CancerLife Announces a New Platform to Address Disparities of Care with Breast Cancer

CancerLife announces the results of a clinical trial where QoL was raised by 14.3% across all care settings, which proves it solution can address disparities of care. - October 29, 2022 - CancerLife

Dr. Pam Gumbs Recognized as a Woman of the Month for September 2022 By P.O.W.E.R. (Professional Organization of Women of Excellence Recognized)

Dr. Pam Gumbs Recognized as a Woman of the Month for September 2022 By P.O.W.E.R. (Professional Organization of Women of Excellence Recognized)

Dr. Pam Gumbs of Berkeley, California has been recognized as a Woman of the Month for September 2022 by P.O.WE.R. (Professional Organization of Women of Excellence Recognized) for her outstanding contributions and achievements in the pharmaceutical field. About Dr. Pam Gumbs Dr. Pam Gumbs is the... - October 26, 2022 - P.O.W.E.R. Professional Organization of Women of Excellence Recognized

Long COVID Care Center Have Recently Published a Medical Report on the Symptoms of Long COVID Brain Fog

Long COVID Care Center Have Recently Published a Medical Report on the Symptoms of Long COVID Brain Fog

During rehabilitation after being infected with COVID-19, many patients said they experienced "brain fog." According to figures given in the study report, about 10% of patients infected with COVID-19 will experience long COVID. At present, it has become customary in the medical community to classify the symptoms of brain and nerve caused by COVID-19 infection as long-term COVID brain fog. - October 26, 2022 - Long COVID Care Center

Kantify and Mcule Harness the Power of Data to Accelerate Drug Discovery

Kantify and Mcule Harness the Power of Data to Accelerate Drug Discovery

Kantify, using its AI technology for drug discovery and Mcule, with its compound sourcing platform, are collaborating to leverage data for better hit prediction. - October 17, 2022 - Mcule

Biolexis Therapeutics Announces Launch of FIELDS, an AI/ML Drug Discovery Platform

Biolexis is the first company to combine a curated historical wet-lab database, including half-a-million targets of binding data points, with an automated AI/ML-augmented discovery platform. - October 14, 2022 - Biolexis Therapeutics Inc.

CallonDoc Provides Immediate Healthcare Support Those Affected by Hurricane Ian

CallonDoc Provides Immediate Healthcare Support Those Affected by Hurricane Ian

CallonDoc is helping those affected by Hurricane Ian by providing immediate access to healthcare. CallonDoc is offering same day online visits and prescriptions for immediate relief and availability to care. - October 08, 2022 - CallonDoc

The IPA Confirms IPAC2022NV Medical Conference at Alexis Park Resort in Las Vegas, NV with CME on Cannabis, Psilocybin, Psychedelics, Mental Health & More

The IPA Confirms IPAC2022NV Medical Conference at Alexis Park Resort in Las Vegas, NV with CME on Cannabis, Psilocybin, Psychedelics, Mental Health & More

The Integrative Providers Association (IPA) is holding its next Annual Integrative Providers Association Conference 2022 at the Alexis Park Resort in Las Vegas, Nevada, from November 13-15, 2022. Included in the IPACs are a variety of Edutainment and Networking Events, Engaging Pre-Recorded Content on Psychedelics, Cannabis and More with 15 AMA PRA Category 1 Credit(s)TM Centered Around Providers “Transitioning to Individualized Wellness Management” - Plus a Bonus Day-3 Clinical Practicum. - October 06, 2022 - Integrative Providers Association

Evidence Partners Rebrands as DistillerSR to Leverage Market Awareness of Its Core Literature Review Platform

The Company Also Bolstered Its Executive Team in Security, Product Management and Operations to Support Accelerating Growth - September 28, 2022 - DistillerSR

NuvOx Appoints Dr. Katy Peters to SAB

NuvOx Pharma, a clinical stage biotechnology company developing a first-in-class therapeutic to treat life-threatening diseases where hypoxia plays a role, appointed Dr. Katy Peters to its Scientific Advisory Board (SAB). Dr. Katy Peters, MD, Ph.D. FAAN is an associate professor of neurology and... - September 22, 2022 - NuvOx Therapeutics

New Decentralized Clinical Trial (DCT) Patient Satisfaction and Participation Report

800 Current and Future Clinical Trial Participants Link Satisfaction and Willingness to Participate with Decentralized Strategies - September 21, 2022 - Life Science Strategy Group, LLC

Integrated Servo Motors Get More Torque

Integrated Servo Motors Get More Torque

AMCI is releasing the SV400E2 Integrated Servo Motor, expanding the torque options available within the integrated servo family. By incorporating a servo motor, drive, and controller in a single package they offer a smaller control system which benefits your bottom line and production time. - September 20, 2022 - AMCI

Virb to Collaborate with Tufts CSDD on CRA Roundtable on October 18, 2022

Virb to Collaborate with Tufts CSDD on CRA Roundtable on October 18, 2022

Event to focus on the connection between CRA experience and performance. - September 20, 2022 - Virb

Record Salesforce Project in the Baltic States: Limedika Picks Salesforce to Streamline Employee Experience

Pharmaceutical company Limedika chooses Salesforce to create an internal employee service center and streamline employee experience across group companies. With nearly 2000 employees, this is one of the largest Salesforce platform deployments in the Baltics. Platform deployment was carried out by specialized full-service Salesforce consultancy Bluelark, which is a part of Agmis technology group. - September 17, 2022 - Agmis

Husson University’s School of Pharmacy Hosted the Rx Abuse Leadership (RALI) Trailer on Campus

Despite recent decreases in teen drug use nationwide, there’s still more to do. In order to help educate and combat overdose and addiction issues locally, Husson partnered with the Rx Abuse Leadership Initiative (RALI) of Maine and Code 3 to increase public awareness of opioid misuse. The University brought a trailer with an educational exhibit set up like a teenager’s bedroom to their Bangor, Maine campus. The trailer is designed to help visitors spot possible warning signs of hidden drugs. - September 14, 2022 - Husson University

Appointments Made to the Sterile Compounding Expert Panel Announced by Pharmacy Stars

The Sterile Compounding Expert Panel (SCXP) was established by Pharmacy Stars on July 7, 2022. Pharmacy Stars executive leadership has appointed key members to serve on SCXP’s panel. They have joined in support of the organization’s mission to strengthen sterile compounding practices in... - September 12, 2022 - Pharmacy Stars, LLC

GENINVO Service Offering Custom Application Development

GENINVO is a leading provider of high-quality, innovative life science tools. GENINVO understand the business challenges of enterprises big and small. Whether you need short-term, focused design support or turnkey product development, GENINVO has the right tools to meet your needs with the help of... - September 07, 2022 - GenInvo, Inc.

Immunize Wisconsin Set to Launch

Immunize Wisconsin Set to Launch

A new statewide immunization coalition, Immunize Wisconsin, will provide fact-based resources, education, and grants. - September 06, 2022 - Wisconsin Chapter of the American Academy of Pediatrics

BOC Sciences Developed Strain Expression Systems to Enhance Fermentation Productivity

BOC Sciences developed strain expression systems for fermentation to help researchers greatly enhance fermentation productivity while significantly reducing costs. - September 02, 2022 - BOC Sciences

10 Great Reasons to Join the Next Generation Pharmaceutical Cleanrooms Conference

SAE Media Group reports: Next Generation Pharmaceutical Cleanrooms Conference 2022 will provide delegates the opportunity to delve into the significant changes that the cleanroom industry is going through. - August 30, 2022 - SAE Media Group

PSL Family wCaregivers to Get Answers; Fearless Caregiver Workshop Sept. 22

Limited complimentary tickets are available for the Fearless Caregiver training. The 25th anniversary Fearless Caregiver Conference tour will come to the Port Saint Lucie Community Center Sept. 22. - August 26, 2022 - Caregiver.com, Inc.

NanoCellect Biomedical Awarded $1.8M Federal Grant to Advance Imaging Flow Cytometry with Artificial Intelligence Technologies

NanoCellect Biomedical Awarded $1.8M Federal Grant to Advance Imaging Flow Cytometry with Artificial Intelligence Technologies

NanoCellect Biomedical Inc., a leader in the development and manufacture of microfluidic cell sorting solutions for cell-based assays, today announced it has received a $1.8 million Phase II Small Business Innovation Research (SBIR) grant through the National Institutes of Health’s National... - August 24, 2022 - NanoCellect Biomedical

Pharma CI Conference Returns Next Month: Meet Hundreds of Industry Leaders at the Top Event for 15+ Years

Pharma CI Conference Returns Next Month: Meet Hundreds of Industry Leaders at the Top Event for 15+ Years

Ready, set, engage! The Pharma CI USA Conference & Exhibition is back in person and ready to deliver the industry-leading experience that has made Pharma CI the gold standard event for more than fifteen years. The much-anticipated return happens this September 21-22 at the Newark Liberty... - August 18, 2022 - Pharma CI Conference

Hospice Home Care Expands to Cover All of Los Angeles County

Hospice Home Care Expands to Cover All of Los Angeles County

Every city in Los Angeles Country will be serviced by Hospice Home Care. The department that has been created will allow doctors, nurses, volunteers and other hospice care professionals to service thousands of patients in the Los Angeles area. - August 08, 2022 - Hospice Home Care

House Rx and QCCA Partner to Improve Medically Integrated Drug Dispensing at Community Oncology Clinics

House Rx and QCCA Partner to Improve Medically Integrated Drug Dispensing at Community Oncology Clinics

House Rx, the platform for medically integrated dispensing of specialty medications, today announced a partnership with the Quality Cancer Care Alliance (QCCA) to provide QCCA-affiliated practices with an analytical snapshot of their in-office specialty drug dispensing operations, known as... - August 08, 2022 - House Rx

Jedsy to Participate at 2022 AACC

Jedsy to Participate at 2022 AACC

Drone delivery made for Laboratories. - July 25, 2022 - Jedsy

Press Releases 101 - 150 of 2,730